With a market capitalization of Rs 15,993 crore, J B Chemicals and Pharmaceuticals Ltd. shares surged 8% on Thursday to reach an intraday high of ₹ 2080 apiece from the previous close price of ₹1923.
At 12.16 am, the Stock was trading at Rs 2053.50 on the BSE, up 7 percent from its previous close.
One of the probable reasons for the stock to hit a high price is the company’s recent announcement of strong Q4 FY 22-23 earnings.
In addition, the company’s board recommended a final dividend of Rs 9.25 (462.50 percent) per equity share with a face value of Rs 2 for the years 2022-23. While the company also subdivided its shares at a ratio of 1:2. That means if 1 share is held by an investor it will become 2 shares.
J.B. Chemicals & Pharmaceuticals Ltd. (JBCPL) is one of India’s fastest-growing pharmaceutical companies engaged in manufacturing a range of innovative specialty products that include various pharmaceutical dosage forms like tablets, injectables, and capsules.
Having a quick walkthrough of the financials reported by the company, In Q4FY23, PAT jumped 3.5% to ₹88 crores as against ₹85 crores in Q4FY22. Revenue stood at ₹762 crore, up by 22% from ₹625 crore in Q4FY22.
On a YoY comparison of the metrics, the revenues significantly improved from ₹2,424 crores during FY 21-22 to ₹3,149 crores in FY 22-23. The PAT numbers have shifted upwards within the timeframe mentioned, from ₹ 386 crores to 410 crores.
According to the latest data pertaining to the shareholding pattern, promoters of the company hold a 53.93 percent stake, and domestic institutional investors (DIIs) hold a 19.08 percent stake in the company for FY 22-23.
Written by Omkar C
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Pharma Stock Jumps 7% after company announces 462.50% dividend and 1:2 stock split appeared first on Trade Brains.
